Crown Bioscience (CrownBio), JSR Life Sciences and Cambridge Quantum Computing (CQC) today announced a partnership agreement to explore the application of quantum technology to drive the identification of multi-gene biomarker discovery for oncology drug discovery.

In confirming the successful implementation of generative modelling on hybrid hardware, CQC and collaborators (IonQ, University of Maryland, University College London and Mind Foundry inter alia) have displayed one of the most powerful applications of quantum computing up to date. The experiments indicate that our approach can be scaled up to handle more complex datasets as the hardware improves in the quality and quantity of qubits.

0
0
without
https://cambridgequantum.com/wp-content/themes/hazel/
https://cambridgequantum.com/
#d8d8d8
style2
paged
Loading posts...
/home/customer/www/cambridgequantum.com/public_html/
#
on
none
loading
#
Sort Gallery
on
yes
yes
off
on
off